期刊文献+

联合应用α受体和M受体阻滞剂提高输尿管软镜手术中输尿管通道鞘置入成功率的效果 被引量:10

Effect ofα-blockers combined with M receptor blockers on improving the success rate of ureteral access sheath insertion in the treatment of flexible ureteroscopy surgery
原文传递
导出
摘要 目的观察联合应用α受体和M受体阻滞剂提高输尿管软镜手术中输尿管通道鞘(UAS)置入成功率的效果。方法将230例肾结石患者随机均分为五组:双J管1组和双J管2组分别于术前放置双J管1周和2周;药物1组和药物2组术前分别口服坦索罗辛+托特罗定和多沙唑嗪+托特罗定1周;对照组不做特殊处理。比较五组输尿管软镜手术中UAS置入成功率。结果 UAS置入成功率:双J管1组91.3%(42/46),双J管2组93.5%(43/46),药物1组87.0%(40/46),药物2组89.1%(41/46),对照组78.3%(36/46)。双J管1组、双J管2组、药物1组和药物2组UAS置入成功率均高于对照组(P<0.01)。结论输尿管软镜手术前联合应用α受体和M受体阻滞剂能达到术前放置双J管类似的效果。 Objective To observe the effect of α-blockers combined with M receptor blockers on improving the success rate of ureteral access sheath(UAS) insertion in the treatment of flexible ureteroscopy surgery. Methods A total of 230 patients with renal calculi was equally randomized into five groups. Groups of A1 and A2 were inserted with double-J stent one and two weeks before UAS insertion.Groups of D1 and D2 were treated with oral tamsulosin + tolterodine and Doxazosin + tolterodine one week before UAS insertion. Group C was not given any special treatment. The success rate of UAS insertion was compared among five groups. Results The success rates of UAS insertion were 91.3%(42/46) for group A1, 93.5% (43/46) for group A2, 87.0% (40/46) for group D1, 89.1%(41/46) for group D2, which were all higher than 78. 3% (36/46) in group C(P〈0. 01). Conclusion Combined use of α-blockers and M receptor blockers can achieve a similar success rate of UAS insertion as double-J stent before flexible ureteroscopy surgery.
出处 《江苏医药》 CAS 2016年第21期2360-2362,共3页 Jiangsu Medical Journal
关键词 输尿管通道鞘 双J管 Α受体阻滞剂 M受体阻滞剂 Ureteral access sheath Double-J stent α-blocker M receptor blocker
  • 相关文献

参考文献1

二级参考文献10

  • 1Chew BH, Lange D. Ureteral stent symptoms and associated infections: a biomaterials perspective[J]. Nat Rev Urol, 2009, 6(8): 440-448.
  • 2Chew BH, Knudsen BH, Denstedt D. The use of stents in eontemporary urology[J]. Curr Opin Urol, 2004, 14(2): 111-115.
  • 3Niyaoka R, Monga M. Ureteral stent discomfort: Etiology and management[J]. Indian J Urol, 2009, 25(4): 455-460.
  • 4Byrne RR, Auge BIG Kourambas J, et al. Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloseopy: a randomized trial[J]. J Endourol, 2002, 16(1): 9-13.
  • 5Joshi HB, Okeke A, Newns N, et al. Characterization of urinary symptoms in patients with ureteral stents[J]. Urology, 2002, 59(4): 511-519.
  • 6Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study[J]. J Urol, 2009, 18(1): 170-176.
  • 7Wang CJ, Huang SW, Chang CH. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study[J]. Urol Res, 2009, 37(3): 147-152.
  • 8Agarwal A, Dhiraaj S, Singhal V, et al. Comparison of efficacy of oxyhutynin and toherodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study[J]. Br J Anaesth, 2006, 96(3): 377-380.
  • 9Lim KT, Kim YT, Lee TY, et al. Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related disconfforts[J]. Korean J Urol, 2011, 52(7): 485-488.
  • 10Yamada S, Ito Y, Tsukada H. α1-Adrenoceptors and muscarinicic receptors in voiding function-binding characteristics of therapeutic agents in relation to the pharmacokinetics[J]. Br J Clin Pharmacol, 2011, 72(2): 205-217.

共引文献11

同被引文献55

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部